Literature DB >> 18520336

Probiotics for children with diarrhea: an update.

Stefano Guandalini1.   

Abstract

This review focuses on the efficacy of probiotics for diarrhea in children in different settings: day-care centers, diarrhea acquired in the hospital, antibiotic-associated diarrhea, and treatment of acute infectious diarrhea. For prevention of diarrhea acquired in day-care centers, 5 randomized and placebo-controlled trials have been published. Probiotics tested were Lactobacillus GG, Bifidobacterium lactis (alone or in combination with Streptococcus thermophilus), and Lactobacillus reuteri. The evidence of their efficacy in these settings is only modest: statistically significant for some strains only and in any case of minimal to mild clinical importance. Few trials have examined the potential role of probiotics in preventing the spread of diarrhea in hospitalized children, an event most commonly due to either rotavirus or Clostridium difficile, and they have yielded conflicting results. Overall, these studies provide only weak evidence on the efficacy of probiotics. On the other hand, a large number of trials on the role of probiotics in preventing the onset of antibiotic-associated diarrhea have been published. Most commonly employed probiotics were Lactobacillus GG, Bifidobacterium spp., Streptococcus spp., and the yeast Saccharomyces boulardii. In general, these trials do show clear evidence of efficacy, with the 2 most effective strains being Lactobacillus GG and S. boulardii. Today, we have a large number of published clinical trials on the role of probiotics in treating sporadic infectious diarrhea in children, and many of them are randomized, blinded, and controlled. They consistently show a statistically significant benefit and moderate clinical benefit of a few, well-identified probiotic strains-mostly Lactobacillus GG and S. boulardii, but also L. reuteri-in the treatment of acute watery diarrhea, primarily rotaviral, in infants and young children of developed countries. Such a beneficial effect seems to result in a reduction of diarrhea duration of little more than 1 day, and to be exerted mostly on diarrhea due to rotavirus. The effect is not only strain-dependent, but also dose-dependent, with doses of at least 10 billion/d being necessary.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520336     DOI: 10.1097/MCG.0b013e3181674087

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  30 in total

1.  Effects of Lactobacillus gasseri BNR17 on body weight and adipose tissue mass in diet-induced overweight rats.

Authors:  Ji-Hee Kang; Sung-Il Yun; Han-Oh Park
Journal:  J Microbiol       Date:  2010-11-03       Impact factor: 3.422

2.  Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection.

Authors:  Nuntra Suwantarat; David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

3.  Improving yield of industrial biomass propagation by increasing the Trx2p dosage.

Authors:  Rocío Gómez-Pastor; Roberto Pérez-Torrado; Emilia Matallana
Journal:  Bioeng Bugs       Date:  2010 Sep-Oct

4.  Porcine small intestinal epithelial cell line (IPEC-J2) of rotavirus infection as a new model for the study of innate immune responses to rotaviruses and probiotics.

Authors:  Fangning Liu; Guohua Li; Ke Wen; Tammy Bui; Dianjun Cao; Yanming Zhang; Lijuan Yuan
Journal:  Viral Immunol       Date:  2010-04       Impact factor: 2.257

5.  Lactobacillus rhamnosus GG on rotavirus-induced injury of ileal epithelium in gnotobiotic pigs.

Authors:  Fangning Liu; Guohua Li; Ke Wen; Shaoping Wu; Yongguo Zhang; Tammy Bui; Xingdong Yang; Jacob Kocher; Jun Sun; Bernard Jortner; Lijuan Yuan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-12       Impact factor: 2.839

6.  Site and clinical significance of Alloscardovia omnicolens and Bifidobacterium species isolated in the clinical laboratory.

Authors:  Steven D Mahlen; Jill E Clarridge
Journal:  J Clin Microbiol       Date:  2009-07-29       Impact factor: 5.948

7.  The effects of maturation on the colonic microflora in infancy and childhood.

Authors:  P Enck; K Zimmermann; K Rusch; A Schwiertz; S Klosterhalfen; J S Frick
Journal:  Gastroenterol Res Pract       Date:  2009-09-16       Impact factor: 2.260

8.  Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection.

Authors:  K Ramirez; Y Ditamo; L Rodriguez; W L Picking; M L van Roosmalen; K Leenhouts; M F Pasetti
Journal:  Mucosal Immunol       Date:  2009-11-18       Impact factor: 7.313

9.  Role of antidiarrhoeal drugs as adjunctive therapies for acute diarrhoea in children.

Authors:  Christophe Faure
Journal:  Int J Pediatr       Date:  2013-03-03

Review 10.  Modulation of vaccine response by concomitant probiotic administration.

Authors:  Catherine Maidens; Caroline Childs; Agnieszka Przemska; Iman Bin Dayel; Parveen Yaqoob
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.